13

PW Medtech Group LtdHKG 1358 Stock Report

Last reporting period 30 Jun, 2023

Updated 13 Nov, 2024

Last price

Market cap $B

0.222

Micro

Exchange

XHKG - Hong Kong Exchange

1358.HK Stock Analysis

13

Uncovered

PW Medtech Group Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

91/100

Moderate score

Market cap $B

0.222

Dividend yield

8.83 %

Shares outstanding

1 564.79 B

PW Medtech Group Limited is an investment holding company principally engaged in the development, manufacturing and sales of medical devices. The Company operates through three business segments. The Infusion Set Business segment is engaged in the manufacturing and sales of infusion sets. The Orthopedic Implant Business segment is engaged in the manufacturing and sales of orthopedic implant products, including product category of trauma, spine and joints. The Regenerative Medical Biomaterial Business segment is engaged in the manufacturing and sales of regenerative medical biomaterial products.

View Section: Eyestock Rating